- Home
- GROV vs CVM Comparison
GROV vs CVM Comparison
Compare GROV & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- CVM
- Stock Information
- Founded
- GROV 2016
- CVM 1983
- Country
- GROV United States
- CVM United States
- Employees
- GROV N/A
- CVM N/A
- Industry
- GROV Package Goods/Cosmetics
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GROV Consumer Discretionary
- CVM Health Care
- Exchange
- GROV Nasdaq
- CVM Nasdaq
- Market Cap
- GROV 53.5M
- CVM 11.8M
- IPO Year
- GROV N/A
- CVM 1987
- Fundamental
- Price
- GROV $1.45
- CVM $3.46
- Analyst Decision
- GROV Hold
- CVM
- Analyst Count
- GROV 1
- CVM 0
- Target Price
- GROV $1.20
- CVM N/A
- AVG Volume (30 Days)
- GROV 536.2K
- CVM 1.6M
- Earning Date
- GROV 08-07-2025
- CVM 08-14-2025
- Dividend Yield
- GROV N/A
- CVM N/A
- EPS Growth
- GROV N/A
- CVM N/A
- EPS
- GROV N/A
- CVM N/A
- Revenue
- GROV $193,427,000.00
- CVM N/A
- Revenue This Year
- GROV N/A
- CVM N/A
- Revenue Next Year
- GROV $6.22
- CVM N/A
- P/E Ratio
- GROV N/A
- CVM N/A
- Revenue Growth
- GROV N/A
- CVM N/A
- 52 Week Low
- GROV $1.02
- CVM $1.98
- 52 Week High
- GROV $1.95
- CVM $66.60
- Technical
- Relative Strength Index (RSI)
- GROV 72.05
- CVM 57.66
- Support Level
- GROV $1.16
- CVM $2.24
- Resistance Level
- GROV $1.84
- CVM $2.71
- Average True Range (ATR)
- GROV 0.11
- CVM 0.51
- MACD
- GROV 0.04
- CVM 0.25
- Stochastic Oscillator
- GROV 60.49
- CVM 25.61
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.